Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

EMEA advises against prescribing of antidepressants in children

April 28, 2005 Sales and Marketing

Doctors across Europe will be discouraged from prescribing most modern antidepressants for children and adolescents following new EMEA advice.Investigations into …
News

Cholesterol drugs boost Schering-Plough

April 26, 2005 Sales and Marketing

News

Strattera sales fall back over continuing safety concerns

April 26, 2005 Sales and Marketing

Lilly say it expects sales of Strattera to fall in 2005 because of continuing concerns over the safety of ADHD …
News

MHRA failing patients, warns report

April 26, 2005 Sales and Marketing

MPs have called for an urgent review of the UK drugs regulator, saying that tougher regulation of the industry is …
News

Bextra withdrawal dents Pfizer’s sales juggernaut

April 22, 2005 Sales and Marketing

The suspension and withdrawal of Pfizer's Cox-II inhibitor Bextra has forced the company to cut its profit forecast for 2005, …
News

US court rules in favour of Lilly’s Zyprexa

April 18, 2005 Sales and Marketing

Lilly's US patent on blockbuster antipsychotic drug Zyprexa (olanzapine) has been upheld, after a Supreme Court ruled against its generic …
News

Japanese companies merge to form Astellas

April 13, 2005 Sales and Marketing

News

Eloxatin and Campto gain new NICE approval

April 13, 2005 Sales and Marketing

NICE has recommended two more chemotherapy drugs for the first-line treatment of advanced colorectal cancer.The institute said that Sanofi-Aventis' Eloxatin …
News

Secrets of a youthful brand

April 12, 2005 Sales and Marketing Pan Advertising, Teva, lilly

 Today, more than ever before, the pharmaceutical industry is constantly being reminded that a blockbuster drug’s days are numbered and …
Feature

New depression treatment relieves sleep problems in patients

April 12, 2005 Sales and Marketing

An innovative new depression drug has shown improved benefits over existing treatments, according to data presented by its manufacturer Servier.Valdoxan …
News

Serono hit by two late-stage failures

April 8, 2005 Research and Development, Sales and Marketing

Serono has halted development of a late-stage psoriasis drug and stopped another trial for a new skin cancer drug.Both drugs …
News

Bextra suspended from European and US markets

April 8, 2005 Sales and Marketing

News

No salesforce purge in Pfizer’s $4 billion cuts

April 7, 2005 Sales and Marketing

Pfizer has set out a $4 billion cost cutting programme for the next three years in an attempt to return …
News

New hepatitis B treatment approved in US

April 6, 2005 Sales and Marketing

Bristol-Myers Squibb has received US approval for its hepatitis B treatment Baraclude after a six-month priority review.Baraclude (entecavir) is BMS's …
News

Interactive sampling

April 4, 2005 Sales and Marketing

The internet has changed the way many of us live our lives, from grocery shopping to booking holidays, but can …
Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026